Alfa specializes in innovative and generic pharmaceutical and nutraceutical industry in Germany. Also, we blazed a new trail in the German Pharmaceutical and nutraceutical industry by successfully implementing the concept of innovation and niche sales and marketing. Today, Alfa is known in German and other EU markets to be a pioneer with unique products in the therapeutic segment of the central nervous system, diabetes, oncology, heart disease, COPD, Mental Health, Dermatology, Eye conditions, and Women’s health.
Alfa has a strong international presence spread across more than 15 countries with operations in regulated and emerging markets like the EU, ANZ, Asia, Middle East, and Africa. The company operates through its wholly subsidiaries or affiliates spread across 6 countries with major setups in Germany, UK, Balkan, Mauritius, and India.
One of the most regulated and evolved pharmaceutical and nutraceutical markets worldwide, the EU has been a veritable learning ground for Alfa. Proven expertise in product development and a strong regulatory knowledge have helped in developing a highly robust product portfolio comprising of different therapeutic areas including central nervous system, diabetes, oncology, heart disease, COPD, mental health, dermatology, eye conditions, and women’s health. Our headquarters in Germany and wholly owned subsidiaries in Balkan region, UK, spearhead Alfa’s operations in the EU territory.
Our core markets are Germany, UK and other European countries. We market our brands through ourdirect sales and marketing team as well as distribute products through various partners.
Alfa doesn’t differentiate between developed and emerging markets, as our quality standards are the same for all the markets. All our products for the emerging markets are manufactured in the EU GMP, PIC/s. WHO GMP and other approved facilities. All these products have CTD dossiers in the English language and come with stability data for various zones.
Our emerging markets area mix of regulated and semi-regulated markets compromising of Russia, CIS, Asia, Africa, Middle East, Central and Latin America. Alfa’s products in the therapeutic areas of respiratory, diabetology, cardiovascular and central nervous system are promoted and supported by our distributors.
Contract Development and Contract Manufacturing Solutions at best
Alfa is committed to serve the pharmaceutical industry across value chain with its well-crafted solutions for the contract manufacturing and formulation development.
We offer end to end solutions for the development and manufacturing whereas our emphasis remains to demonstrate what additional value our services can offer or if they can address any unmet needs. We constantly strive for innovative solutions, be it in terms of manufacturing or offering differentiated products.
Our research team is well experienced and trained to develop complex formulations and innovative technologies while adhering to the recent ICH guidelines. Alfa has multiple research and manufacturing sites catering to all dosage forms and specialised therapeutic segments which require dedicated manufacturing facility like antineoplastics, cephalosporins, potent drugs etc.
Alfa is poised to be a reliable and long-term partner to pharmaceutical and consumer health care customers around the world with its comprehensive solutions, experienced team and EU GMP approved manufacturing facilities.
The firm’s horizontal and vertical integration in selling and marketing capabilities enable our pharmaceutical partners and global healthcare markets to receive medicine more swiftly and catering to wider populations in need.
Alfa exclusively provides global pharmaceutical industry with the following relatable cGMP quality-value driven solutions in:
- Pharmaceutical products and
- Nutraceutical products